Overview

Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if AzaSite Plus is effective and safe for the treatment of blepharoconjunctivitis compared to AzaSite alone and Dexamethasone alone.

Phase:

Phase 3

Details

Lead Sponsor:

InSite Vision
Sun Pharma Global FZE

Treatments:

Azithromycin
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate